Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα ...
3 days ago · INDIANAPOLIS and BOSTON, Mass., Jan. 13, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Scorpion Therapeutics, Inc. ("Scorpion"), a private biotechnology company developing small molecule precision oncology therapies, today announced a definitive agreement for Lilly to acquire Scorpion's PI3Kα inhibitor program STX-478. STX-478 is ...
Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα ...
2 days ago · INDIANAPOLIS and BOSTON, Mass., Jan. 13, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Scorpion Therapeutics, Inc. ("Scorpion"), a private biotechnology company developing small ...
Eli Lilly to buy Scorpion Therapeutics' cancer therapy for up to …
2 days ago · Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...
Eli Lilly To Buy Scorpion Therapeutics' Experimental Cancer …
2 days ago · (RTTNews) - Eli Lilly and Company (LLY) on Monday said it has agreed to buy Scorpion Therapeutics' experimental cancer therapy PI3Ka inhibitor program STX-478 for up to $2.5 billion in cash.
Eli Lilly to Buy Scorpion Therapeutics Drug Program in $2.5 …
2 days ago · Eli Lilly has agreed to acquire Scorpion Therapeutics' breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...
Eli Lilly to acquire cancer program from Scorpion Therapeutics
2 days ago · SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.
Lilly acquires Scorpion Therapeutics in deal worth up to $2.5B
2 days ago · Eli Lilly and Co. announced Monday that it is buying Boston-based Scorpion Therapeutics and its targeted breast cancer treatment program in a deal worth up to $2.5 billion. The Indianapolis-based ...
Eli Lilly in advanced talks to buy US cancer biotech for up to $2.5bn
5 days ago · Eli Lilly, the world’s largest drugmaker by market value, is in advanced talks to buy cancer-focused biotech Scorpion Therapeutics in a deal worth up to $2.5bn, according to people close to the ...
Lilly to Pay as Much as $2.5 Billion for Scorpion’s Cancer Drug
2 days ago · Eli Lilly & Co. will pay as much as $2.5 billion in cash to acquire a cancer drug that Scorpion Therapeutics Inc. is testing in early and mid-stage trials.
Eli Lilly to acquire Scorpion Therapeutics’ STX-478 program for …
3 days ago · The company states: “Eli Lilly and Scorpion Therapeutics announced a definitive agreement for Lilly to acquire Scorpion’s PI3Kalpha inhibitor program STX-478. STX-478 is a once-daily oral ...
- Some results have been removed